Gilead Sciences
GILD
#106
Rank
A$261.43 B
Marketcap
A$210.84
Share price
0.17%
Change (1 day)
16.99%
Change (1 year)

Gilead Sciences (GILD) - Total assets

Total assets on the balance sheet as of June 2026 : A$70.75 Billion

According to Gilead Sciences's latest financial reports the company's total assets are A$70.75 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Gilead Sciences - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31A$88.12 B-7.09%
2024-12-31A$94.84 B4.02%
2023-12-31A$91.18 B-1.77%
2022-12-31A$92.82 B-0.96%
2021-12-31A$93.72 B5.36%
2020-12-31A$88.96 B1.07%
2019-12-31A$88.02 B-2.62%
2018-12-31A$90.38 B0.4%
2017-12-31A$90.02 B13.89%
2016-12-31A$79.04 B11.34%
2015-12-31A$70.99 B67.6%
2014-12-31A$42.35 B67.33%
2013-12-31A$25.31 B23.85%
2012-12-31A$20.43 B21.12%
2011-12-31A$16.87 B47.87%
2010-12-31A$11.41 B5.71%
2009-12-31A$10.79 B9.81%
2008-12-31A$9.83 B47.33%
2007-12-31A$6.67 B28.76%
2006-12-31A$5.18 B0.7%
2005-12-31A$5.14 B84.76%
2004-12-31A$2.78 B33.2%
2003-12-31A$2.09 B-8.52%
2002-12-31A$2.28 B46.82%
2001-12-31A$1.55 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
A$288.18 B 307.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$288.28 B 307.46%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$193.66 B 173.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$203.93 B 188.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$137.07 B 93.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$45.98 B-35.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$9.40 B-86.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$39.30 B-44.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$186.04 B 162.96%๐Ÿ‡บ๐Ÿ‡ธ USA